A brief perspective on the diverging theories of lymphatic targeting with colloids

References

• ChoH-YLeeY-BNano-sized drug delivery systems for lymphatic deliveryJ Nanosci Nanotechnol201414186888024730304
   PubMedGoogle Scholar
• HawleyAEDavisSSIllumLTargeting of colloids to lymph nodes: Influence of lymphatic physiology and colloidal characteristicsAdv Drug Deliv Rev1995171129148
   Web of Science ®Google Scholar
• SiramKChellanVRNatarajanTSolid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluationExpert Opin Drug Deliv20141191351136524847779
   PubMed Web of Science ®Google Scholar
• SheebaCJMarslinGRevinaAMFranklinGSignaling pathways influencing tumor microenvironment and their exploitation for targeted drug deliveryNanotechnol Rev201432123151
   Web of Science ®Google Scholar
• OussorenCStormGLiposomes to target the lymphatics by subcutaneous administrationAdv Drug Deliv Rev2001501–214315611489337
   PubMed Web of Science ®Google Scholar
• RaoDAForrestMLAlaniAWGKwonGSRobinsonJRBiodegradable PLGA based nanoparticles for sustained regional lymphatic drug deliveryJ Pharm Sci20109942018203119902520
   PubMed Web of Science ®Google Scholar
• TakakuraYAtsumiRHashidaMSezakiHDevelopment of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administrationInt J Pharm1987371–2145154
   Google Scholar
• KaurCDNaharMJainNKLymphatic targeting of zidovudine using surface-engineered liposomesJ Drug Target2008161079880519005941
   PubMed Web of Science ®Google Scholar
• PatelHMBoodleKMVaughan-JonesRAssessment of the potential uses of liposomes for lymphoscintigraphy and lymphatic drug delivery. Failure of 99m-technetium marker to represent intact liposomes in lymph nodesBiochim Biophys Acta1984801176866087919
   PubMed Web of Science ®Google Scholar
• KaminskasLMKotaJMcLeodVMKellyBDKarellasPPorterCJPEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in ratsJ Control Release2009140210811619686787
   PubMed Web of Science ®Google Scholar
• KimCKLeeMKHanJHLeeBJPharmacokinetics and tissue distribution of methotrexate after intravenous injection of differently charged liposome-entrapped methotrexate to ratsInt J Pharm199410812129
   Google Scholar
• LiSDHuangLPharmacokinetics and biodistribution of nanoparticlesMol Pharm20085449650418611037
   PubMed Web of Science ®Google Scholar
• LevchenkoTSRammohanRLukyanovANWhitemanKRTorchilinVPLiposome clearance in mice: The effect of a separate and combined presence of surface charge and polymer coatingInt J Pharm20022401–29510212062505
   PubMed Web of Science ®Google Scholar
• MortimerGMButcherNJMusumeciAWDengZJMartinDJMinchinRFCryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterialsACS Nano2014843357336624617595
   PubMed Web of Science ®Google Scholar
• GargMJainNKReduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomesJ Drug Target200614111116603446
   PubMed Web of Science ®Google Scholar
• MangatSPatelHMLymph node localization of non-specific antibody-coated liposomesLife Sci19853620191719253990516
   PubMed Web of Science ®Google Scholar
• OussorenCZuidemaJCrommelinDJAStormGLymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid doseBiochim Biophys Acta1997132822612729315622
   PubMed Web of Science ®Google Scholar
• WuMSRobbinsJCBugianesiRLPonpipomMMShenTYModified in vivo behavior of liposomes containing synthetic glycolipidsBiochim Biophys Acta1981674119297236728
   PubMedGoogle Scholar
• ReddySTvan der VliesAJSimeoniEExploiting lymphatic transport and complement activation in nanoparticle vaccinesNat Biotechnol200725101159116417873867
   PubMed Web of Science ®Google Scholar
• OussorenCVelinovaMScherphofGVan Der WantJJVan RooijenNStormGLymphatic uptake and biodistribution of liposomes after subcutaneous injection IV. Fate of liposomes in regional lymph nodesBiochim Biophys Acta1998137022592729545576
   PubMed Web of Science ®Google Scholar
• FengLZhangLLiuMRoles of dextrans on improving lymphatic drainage for liposomal drug delivery systemJ Drug Target201018316817820136463
   PubMed Web of Science ®Google Scholar
• BailonPWonCPEG-modified biopharmaceuticalsExpert Opin Drug Deliv20096111619236204
   PubMed Web of Science ®Google Scholar
• BiswasSDodwadkarNSDeshpandePPParabSTorchilinVPSurface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activityEur J Pharm Biopharm201384351752523333899
   PubMed Web of Science ®Google Scholar
• MarslinGRevinaAMKhandelwalVKMBalakumarKSheebaCJFranklinGPEGylated ofloxacin nanoparticles render strong antibacterial activity against many clinically important human pathogensColloids Surf B Biointerfaces2015132627026005932
   PubMed Web of Science ®Google Scholar
• NakamuraKYamashitaKItohYYoshinoKNozawaSKasukawaHComparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methodsBiochim Biophys Acta20121818112801280722766474
   PubMed Web of Science ®Google Scholar
• OwensDEPeppasNAOpsonization, biodistribution, and pharmacoki-netics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• MoghimiSMHawleyAEChristyNMGrayTIllumLDavisSSSurface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodesFEBS Lett1994344125308181558
   PubMed Web of Science ®Google Scholar
• MuellerSNTianSDeSimoneJMRapid and persistent delivery of antigen by lymph node targeting PRINT nanoparticle vaccine carrier to promote humoral immunityMol Pharm20151251356136525817072
   PubMedGoogle Scholar
• YangFFuDLLongJNiQXMagnetic lymphatic targeting drug delivery system using carbon nanotubesMed Hypotheses200870476576717910909
   PubMed Web of Science ®Google Scholar
• ChangHIYehMKClinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyInt J Nanomedicine20127496022275822
   PubMed Web of Science ®Google Scholar
• WeissigVPettingerTMurdockNNanopharmaceuticals (part 1): products on the marketInt J Nanomedicine201494357437325258527
   PubMed Web of Science ®Google Scholar
• SannaVPalaNSechiMTargeted therapy using nanotechnology: focus on cancerInt J Nanomedicine20149146748324531078
   PubMed Web of Science ®Google Scholar
• AliMAfzalMBhattacharyaSMAhmadFJDindaAKNanopharmaceuticals to target antifilarials: a comprehensive reviewExpert Opin Drug Deliv201310566567823427945
   PubMed Web of Science ®Google Scholar
• GengYDalhaimerPCaiSShape effects of filaments versus spherical particles in flow and drug deliveryNat Nanotechnol20072424925518654271
   PubMed Web of Science ®Google Scholar
• KamalyNXiaoZValenciaPMRadovic-MorenoAFFarokhzadOCTargeted polymeric therapeutic nanoparticles: design, development and clinical translationChem Soc Rev20124172971301022388185
   PubMed Web of Science ®Google Scholar
• SchroederAHellerDAWinslowMMTreating metastatic cancer with nanotechnology. 2012Nat Rev Cancer2011121395022193407
   PubMed Web of Science ®Google Scholar
• GuptaSRathaurSFilarial glutathione S-transferase: its induction by xenobiotics and potential as drug targetActa Biochim Pol200552249350015912210
   PubMedGoogle Scholar